These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22836048)

  • 41. Dose-volume analysis of radiation pneumonitis in non-small-cell lung cancer patients treated with concurrent cisplatinum and etoposide with or without consolidation docetaxel.
    Barriger RB; Fakiris AJ; Hanna N; Yu M; Mantravadi P; McGarry RC
    Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1381-6. PubMed ID: 20231061
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Do angiotensin-converting enzyme inhibitors reduce the risk of symptomatic radiation pneumonitis in patients with non-small cell lung cancer after definitive radiation therapy? Analysis of a single-institution database.
    Wang H; Liao Z; Zhuang Y; Xu T; Nguyen QN; Levy LB; O'Reilly M; Gold KA; Gomez DR
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1071-7. PubMed ID: 24161424
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Severity of radiation pneumonitis, from clinical, dosimetric and biological features: a pilot study.
    Aso S; Navarro-Martin A; Castillo R; Padrones S; Castillo E; Montes A; Martínez JI; Cubero N; López R; Rodríguez L; Palmero R; Manresa F; Guerrero T; Molina M
    Radiat Oncol; 2020 Oct; 15(1):246. PubMed ID: 33109238
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Relationship of dose-volume histogram parameters and computed tomography grading of radiation-induced lung injury in patients with non-small cell lung cancer treated by three-dimensional conformal radiotherapy].
    Xing J; Li JB; Yu JM; Lu J; Xu M; Fan TY; Shao Q; Guo SF
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):676-81. PubMed ID: 19173909
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lung Size and the Risk of Radiation Pneumonitis.
    Briere TM; Krafft S; Liao Z; Martel MK
    Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):377-84. PubMed ID: 26675062
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predicting radiation pneumonitis after stereotactic ablative radiation therapy in patients previously treated with conventional thoracic radiation therapy.
    Liu H; Zhang X; Vinogradskiy YY; Swisher SG; Komaki R; Chang JY
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):1017-23. PubMed ID: 22543216
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predicting pneumonitis risk: a dosimetric alternative to mean lung dose.
    Tucker SL; Mohan R; Liengsawangwong R; Martel MK; Liao Z
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):522-7. PubMed ID: 22580121
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of clinical and dosimetric factors associated with severe acute radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemotherapy and intensity-modulated radiotherapy.
    Shi A; Zhu G; Wu H; Yu R; Li F; Xu B
    Radiat Oncol; 2010 May; 5():35. PubMed ID: 20462424
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Can serum markers be used to predict acute and late toxicity in patients with lung cancer? Analysis of RTOG 91-03.
    Hartsell WF; Scott CB; Dundas GS; Mohiuddin M; Meredith RF; Rubin P; Weigensberg IJ
    Am J Clin Oncol; 2007 Aug; 30(4):368-76. PubMed ID: 17762437
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Changes in global function and regional ventilation and perfusion on SPECT during the course of radiotherapy in patients with non-small-cell lung cancer.
    Yuan ST; Frey KA; Gross MD; Hayman JA; Arenberg D; Cai XW; Ramnath N; Hassan K; Moran J; Eisbruch A; Ten Haken RK; Kong FM
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e631-8. PubMed ID: 22197235
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Initial report on feasibility of PET/CT-based image-guided moderate hypofractionated thoracic irradiation in node-positive non-small cell lung Cancer patients with poor prognostic factors and strongly diminished lung function: a retrospective analysis.
    Eze C; Taugner J; Roengvoraphoj O; Schmidt-Hegemann NS; Käsmann L; Wijaya C; Belka C; Manapov F
    Radiat Oncol; 2019 Sep; 14(1):163. PubMed ID: 31484542
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The impact of adjuvant brachytherapy with sublobar resection on pulmonary function and dyspnea in high-risk patients with operable disease: preliminary results from the American College of Surgeons Oncology Group Z4032 trial.
    Fernando HC; Landreneau RJ; Mandrekar SJ; Hillman SL; Nichols FC; Meyers B; DiPetrillo TA; Heron D; Jones DR; Daly BD; Starnes SL; Hatter JE; Putnam JB
    J Thorac Cardiovasc Surg; 2011 Sep; 142(3):554-62. PubMed ID: 21724195
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Results of a phase I dose-escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma.
    Rosenzweig KE; Fox JL; Yorke E; Amols H; Jackson A; Rusch V; Kris MG; Ling CC; Leibel SA
    Cancer; 2005 May; 103(10):2118-27. PubMed ID: 15830346
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Factors Associated With Early Mortality in Patients Treated With Concurrent Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer.
    Warner A; Dahele M; Hu B; Palma DA; Senan S; Oberije C; Tsujino K; Moreno-Jimenez M; Kim TH; Marks LB; Rengan R; De Petris L; Ramella S; De Ruyck K; De Dios NR; Bradley JD; Rodrigues G
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):612-20. PubMed ID: 26867890
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Non-small cell lung cancer: risk factors of radiation pneumonitis].
    Giroux Leprieur E; Fernandez D; Chatellier G; Klotz S; Giraud P; Durdux C
    Cancer Radiother; 2012; 16(4):257-62. PubMed ID: 22748977
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dose and volume as predictive factors of pulmonary toxicity.
    Trodella L; Ramella S; Salvi G; Arcangeli S; Ciresa M; Massaccesi M; Macchia G; D'Angelillo RM
    Rays; 2005; 30(2):175-80. PubMed ID: 16294911
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study.
    Rancati T; Ceresoli GL; Gagliardi G; Schipani S; Cattaneo GM
    Radiother Oncol; 2003 Jun; 67(3):275-83. PubMed ID: 12865175
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prediction of radiation pneumonitis by dose - volume histogram parameters in lung cancer--a systematic review.
    Rodrigues G; Lock M; D'Souza D; Yu E; Van Dyk J
    Radiother Oncol; 2004 May; 71(2):127-38. PubMed ID: 15110445
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Changes in pulmonary function and their correlation with dose-volume parameters in patients undergoing stereotactic body radiotherapy for lung cancer.
    Takemoto S; Shibamoto Y; Hashizume C; Miyakawa A; Murai T; Yanagi T; Sugie C; Nagai A
    J Radiat Res; 2021 Mar; 62(2):338-345. PubMed ID: 33480428
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combined analysis of V20, VS5, pulmonary fibrosis score on baseline computed tomography, and patient age improves prediction of severe radiation pneumonitis after concurrent chemoradiotherapy for locally advanced non-small-cell lung cancer.
    Tsujino K; Hashimoto T; Shimada T; Yoden E; Fujii O; Ota Y; Satouchi M; Negoro S; Adachi S; Soejima T
    J Thorac Oncol; 2014 Jul; 9(7):983-990. PubMed ID: 24922010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.